• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Rare APOE missense variants V236E and R251G associated with substantial reduction in risk of Alzheimer disease

byYuchen DaiandMichael Pratte
June 2, 2022
in Chronic Disease, Neurology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. APOE ε3 (V236E) and APOE ε4 (R251G), 2 rare missense genetic variants, both had a substantial association with reducing the risk of Alzheimer disease.

2. These findings further validated the protective effect of the V236E variant and has revealed a novel protective missense variant on APOE ε4.

Evidence Rating Level: 3 (Average)

Study Rundown: Late-onset Alzheimer disease (AD) has been strongly linked to the protective APOE ε2 and risk-increasing APOE ε4 alleles, however, the mechanism and pathogenesis behind this is poorly understood. This genetic association study examined the association between rare missense variants on APOE with risk of AD. The main outcome was the estimated AD risk associated with each missense variant, where secondary analysis evaluated associations with age at onset and risk of conversion to AD. Among 544 384 participants, including 67 896 patients with AD, 28 484 with proxy-AD, and 340 306 controls, 2 rare missense genetic variants – APOE ε3 [V236E] and APOE ε4 [R251G] – significantly reduced the risk of AD by >60% and >50%, respectively. These findings further validated the protective effect of the V236E variant and has revealed a novel protective missense variant on APOE ε4. A limitation of this study was the lack of a direct clinical diagnosis of AD in the UK Biobank cohort that was included in the analysis.

Click to read the study in JAMA Neurology

Click to read an accompanying editorial in JAMA Neurology

RELATED REPORTS

The Scan by 2 Minute Medicine®: Versatile Ozempic, Healthcare Reform, Unlocking the Brain, and Chickens and the Next Pandemic:

Caregivers of people with dementia may benefit from online decision aid when managing firearm access

High-sugar dietary pattern associated with increased risk of dementia

Relevant Reading: APOE and dementia—resequencing and genotyping in 105,597 individuals

In-Depth [case-control]: This genetic association study included 544 384 participants (312 476 [57.4%] female; mean [SD] age, 64.9 [15.2] years) between September 2015 and November 2021. The study combined case-control, family- and population-based, and longitudinal AD-related cohorts. Stage 1 (sequenced discovery) included 11 868 individuals with AD and 11 934 controls. Stages 2 and 3 included 84 513 individuals with AD and proxy-AD and 328 372 controls from microarray imputed and UK Biobank whole-exome sequencing cohorts. Overall, 2 missense variants were associated with a 2 to 3-fold decreased AD risk: APOE ε4 (R251G) (OR, 0.44; 95%CI, 0.33-0.59; P = 4.7 x 10−8) and APOE ε3 (V236E) (OR, 0.37; 95%CI, 0.25-0.56; P = 1.9 x 10−6). Compared with noncarriers, the cumulative incidence of AD in carriers of these variants was found to grow slower with age.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Alzheimer’s diseasegene testing
Previous Post

#VisualAbstract: Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial

Next Post

Prenatal exposure to antiseizure medication associated with increased risk of autism and intellectual disability

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Versatile Ozempic, Healthcare Reform, Unlocking the Brain, and Chickens and the Next Pandemic:

January 7, 2025
Public Health

Caregivers of people with dementia may benefit from online decision aid when managing firearm access

October 22, 2024
Neurology

High-sugar dietary pattern associated with increased risk of dementia

July 25, 2024
Amyloid may cause distant cerebral hypometabolism in Alzheimer’s
Chronic Disease

APOE3 Christchurch heterozygosity may delay cognitive impairment in Alzheimer’s disease

June 25, 2024
Next Post
Paternal factors associated with short interpregnancy interval

Prenatal exposure to antiseizure medication associated with increased risk of autism and intellectual disability

Parents desensitized with increasing exposure to movie violence/sex

Limits to screen use associated with increased non-sedentary behavior in children

2 Minute Medicine Rewind June 6, 2022

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Oral vancomycin may be effective for pouchitis in inflammatory bowel disease
  • Inebilizumab improves outcome in patients generalized myasthenia gravis
  • Medbridge turns any phone into a motion-capture coach for at-home rehab
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.